CymaBay Therapeutics, Inc. announced the appointment of Dr. Éric Lefebvre to its Board of Directors. Dr. Lefebvre is serving as Chief Medical Officer of Pliant Therapeutics, Inc., a biopharmaceutical company, where he has served as such since May 2018. Prior to joining Pliant, Dr. Lefebvre served as the Vice President of Research and Development at Allergan plc, a global pharmaceutical company, from November 2016 until April 2018.
CymaBay Therapeutics, Inc.
Equities
CBAY
US23257D1037
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.11% | 21.83B | |
-11.21% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |